| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 67501 |
Mal-PEG2-Val-Cit-PABA（CAS号：1662687-83-3） |
88 |
WYQ |
2024-12-18 |
| 67502 |
CAS号：1096584-62-1， Mal-Val-Cit-PAB-PNP |
66 |
WYQ |
2024-12-18 |
| 67503 |
Mal-amido-PEG2-Val-Cit-PAB-OH，马来酰亚胺-酰胺-二聚乙二醇-缬氨酸-瓜氨酸-PAB-羟基 |
68 |
WYQ |
2024-12-18 |
| 67504 |
CAS号：1949793-41-2 ，Mal-amido-PEG4-Val-Cit-PAB-OH |
76 |
WYQ |
2024-12-18 |
| 67505 |
DOTA-伊班膦酸 DOTA-IBA |
68 |
h |
2024-12-18 |
| 67506 |
FA-DOTA-PEG-PLGA 叶酸-DOTA-聚乙二醇-聚乳酸-羟基乙酸共聚物 |
79 |
h |
2024-12-18 |
| 67507 |
DOTA-泛素29-41 |
66 |
h |
2024-12-18 |
| 67508 |
cas:1226403-39-9，N-(2-(3,4-Difluorophenoxy)ethyl)-4-formylbenzamide |
73 |
kx |
2024-12-18 |
| 67509 |
Cu-64 DOTA-曲妥珠单抗 Cu-64-Herceptin |
115 |
h |
2024-12-18 |
| 67510 |
CAS号：2112738-13-1 ，Mal-amido-PEG2-Val-Cit-PAB-PNP |
70 |
WYQ |
2024-12-18 |
| 67511 |
CAS号：2055041-40-0 ， Azido-PEG1-Val-Cit-PAB-OH |
88 |
WYQ |
2024-12-18 |
| 67512 |
cas:1226006-55-8，N-(2-(3-Ethoxyphenoxy)ethyl)-4-formylbenzamide， ADC试剂 |
65 |
kx |
2024-12-18 |
| 67513 |
DOTA-LTVSPWY 双功能螯合剂DOTA偶联肽LTVSPWY |
66 |
h |
2024-12-18 |
| 67514 |
CAS号：2055024-65-0 ，Azido-PEG3-Val-Cit-PAB-OH |
75 |
WYQ |
2024-12-18 |
| 67515 |
DOTA-CCK-66 大环DOTA偶联CCK2R靶向化合物CCK-66 |
152 |
h |
2024-12-18 |
| 67516 |
cas:1228153-04-5，4-Formyl-N-(2-(naphthalen-2-yloxy)ethyl)benzamide |
92 |
kx |
2024-12-18 |
| 67517 |
抗DOTA IgG-scFv BsAb anti-DOTA IgG-scFv BsAb |
91 |
h |
2024-12-18 |
| 67518 |
cas:1226217-30-6，4-Formyl-N-(2-(4-isopropylphenoxy)ethyl)benzamide |
78 |
kx |
2024-12-18 |
| 67519 |
DOTA-rL-A9肽 DOTA偶联核定位序列(NLS)-移植的her 2-受体亲和肽 |
94 |
h |
2024-12-18 |
| 67520 |
cas:796073-59-1，2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
69 |
kx |
2024-12-18 |
| 67521 |
DOTA-E[c(RGDFK)]2 双功能螯合剂偶联的RGD多肽E[c(RGDfK)]2 |
73 |
h |
2024-12-18 |
| 67522 |
DBCO-C4-Val-Cit-PABC-PNP，分子式：C46H49N7O10 |
78 |
WYQ |
2024-12-18 |
| 67523 |
DBCO-(PEG)3-VC-PAB-MMAE，CAS号：57103-68-1 |
53 |
WYQ |
2024-12-18 |
| 67524 |
cas:1134280-65-1，2,5-Dioxopyrrolidin-1-yl 3-((2,4-difluorobenzyl)oxy)propanoate |
74 |
kx |
2024-12-18 |
| 67525 |
DBCO-PEG3-acetic-Val-Cit-PAB（二苯并环辛炔） |
82 |
WYQ |
2024-12-18 |
| 67526 |
cas:1824718-79-7，SPDH， ADC试剂 |
80 |
kx |
2024-12-18 |
| 67527 |
cas:1232769-29-7，2,5-dioxopyrrolidin-1-yl 19-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-19-oxo-4,7,10,13,16-pentaoxanonadecan-1-oate |
79 |
kx |
2024-12-18 |
| 67528 |
Amino-PEG2-VG-N-Bis(PEG1-azide)，氨基-二聚乙二醇-VG-N-双（一聚乙二醇-叠氮） |
110 |
WYQ |
2024-12-18 |
| 67529 |
Alkyne-Val-Cit-PAB-FAM，炔-VAL-CIT-PAB-FAM |
67 |
WYQ |
2024-12-18 |
| 67530 |
cas:1226218-43-4，4-Formyl-N-(2-(2,3,6-trimethylphenoxy)ethyl)benzamide |
62 |
kx |
2024-12-18 |
| 67531 |
双功能螫合剂DOTA偶联MAG3 DOTA-MAG3 |
100 |
h |
2024-12-18 |
| 67532 |
Alkyne-Val-Cit-PAB-PNP，炔-Val-Cit-PAB-PNP |
82 |
WYQ |
2024-12-18 |
| 67533 |
DOTA-MSH2 金属螯合剂DOTA偶联二聚体肽(MSH2) |
82 |
h |
2024-12-18 |
| 67534 |
cas:796073-64-8，(S)-2,5-Dioxopyrrolidin-1-yl 4-(methyldisulfanyl)pentanoate |
66 |
kx |
2024-12-18 |
| 67535 |
N,N-二乙基正辛硫基乙酰胺,(N,N-Diethyl-α-(OctlyThio)-Acetamide)简称DOTA |
65 |
h |
2024-12-18 |
| 67536 |
cas:437655-95-3，Fmoc-NH-PEG4-CH2COOH， 5,8,11,14-四氧杂-2-氮杂十六碳二酸 1-芴甲基酯 |
78 |
kx |
2024-12-18 |
| 67537 |
Val-Ala-PAB-OH |
99 |
zyl |
2024-12-18 |
| 67538 |
DOTA-Bz-Cys-RGD dimer 双功能螯合剂修饰Cys-RGD dimer |
75 |
h |
2024-12-18 |
| 67539 |
cas:874208-92-1，m-PEG7-NHS ester， ADC试剂 |
85 |
kx |
2024-12-18 |
| 67540 |
Boc-PEG4-Val-Ala-PAB-PNP |
81 |
zyl |
2024-12-18 |
| 67541 |
111 In-奥曲肽(Octreo Scan) |
269 |
h |
2024-12-18 |
| 67542 |
POSS-DOTA 大环配体DOTA偶联七异丁基-氨丙基六面体倍半硅氧烷POSS |
75 |
h |
2024-12-18 |
| 67543 |
cas:164332-88-1，N-Boc-PEG1-bromide， [2-(2-溴乙氧基)乙基]氨基甲酸叔丁酯 |
60 |
kx |
2024-12-18 |
| 67544 |
DOTA-Substance P DOTA-SP |
88 |
h |
2024-12-18 |
| 67545 |
Mal-amido-PEG8-val-gly-PAB-OH CAS:2353409-52-4 |
77 |
zyl |
2024-12-18 |
齐岳微信公众号
官方微信
库存查询